Androgen-induced growth inhibition of androgen receptor expressing androgen-independent prostate cancer cells is mediated by increased levels of neutral endopeptidase

Endocrinology

Volumn 141, Issue 5, 2000, Pages 1699-1704

  Shen, Ruoqian ^a   Sumitomo, Makoto ^a   Dai, Jie ^a   Harris, Adam ^a   Kaminetzky, David ^a   Gao, Min ^a   Burnstein, Kerry L ^b   Nanus, David M ^a,c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; MEMBRANE METALLOENDOPEPTIDASE; PHOSPHORAMIDON;

ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL SURFACE; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME ASSAY; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION;

EID: 0034456723     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.5.7463     Document Type: Article

References (33)

1. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer
2. p53 is mutated in a subset of advanced-stage prostate cancers
3. Growth factor involvement in progression of prostate cancer
4. Neuroendocrine differentiation in prostatic carcinoma
5. Neuroendocrine differentiation and the bombesib/gastrin releasing peptide family of neuropeptides in the progresssion of human prostate cancer
6. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer
7. Androgen receptor gene amplification: A possible molecular mechanism for androgen deprivation therapy failure in prostate cancer
8. Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells
9. Evidence for a novel mechanism of androgen resistance in the human prostate cell line, PC-3
10. Androgen-induced inhibition of cell proliferation in an androgen-insensitive prostate cancer cell line (PC-3) transfected with a human androgen receptor complementary DNA
11. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor
12. Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells
13. Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor
14. Human prostate tumor growth in athymic mice: Inhibition by androgens and stimulation by finasteride
15. Progression of LNCaP prostate tumor cells during androgen deprivation: Hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest
16. Activation of Rb and decline in androgen receptor protein precede retinoic acid-induced apoptosis in androgen-dependent LNCaP cells and their androgen-independent derivative
17. Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression
18. LNCaP-OM, a new androgen-resistant prostate cancer subline
19. Mutation and expression of the low affinity neurotropin receptor in human malignant melanoma
20. Inhibitory potency of various peptides on enkephalinase activity from mouse striatum
21. CGS 24128: A long-acting inhibitor of neutral endopeptidase 3.4.24.11
22. Androgens inhibit the proliferation of a variant of the human prostate cancer cell line LNCaP
23. Progesterone-regulated cyclic modulation of membrane metalloendopeptidase (enkephalinase) in human endometrium
24. Cytokines and glucocorticoids modulate human bronchial epithelial cell peptidases
25. Glucocorticoids and protein kinase C regulate neutral endopeptidase 24.11 in human vascular smooth muscle cells
26. Identification and characterization of two androgen response regions in the human neutral endopeptidase gene
27. Organization of the gene encoding common acute lymphoblastic leukemia antigen (neutral endopeptidase 24.11): Multiple mirdexons and separate 5′ untranslated regions
28. Analysis of the human CD10/neutral endopeptidase 24.11 promotor region: Two separate regulatory elements
29. Methylation of the neutral endopeptidase gene CpG island in human prostate cancer
30. Cell-surface peptidases as modulators of growth and differentiation
31. Hematopoietic differentiation antigens that are membrane-associated enzymes: Cutting is the key!
32. Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 DU-145: Internalization of receptor bound 125(supercript 125)I(Tyr supercript 4) bombesin by tumor cells
33. Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer